Home > Riviste > Minerva Cardioangiologica > Fascicoli precedenti > Minerva Cardioangiologica 2018 April;66(2) > Minerva Cardioangiologica 2018 April;66(2):213-20

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA CARDIOANGIOLOGICA

Rivista sulle Malattie del Cuore e dei Vasi


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

REVIEW  DIFFERENT APPROACHES TO AORTIC VALVE TREATMENT: SUTURELESS-AVR VERSUS TAVI


Minerva Cardioangiologica 2018 April;66(2):213-20

DOI: 10.23736/S0026-4725.17.04550-9

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

The future of surgical aortic valve replacement and the role of sutureless technology

Selim ISBIR

Department of Cardiovascular Surgery, Marmara University Medical School, Pendik, Istanbul, Turkey


PDF  


Aortic valve stenosis has become the most frequent type of valve disease in worldwide. Surgical aortic valve replacement is still the gold standard therapy. More recently transcatheter aortic valve implantation has been demonstrated to be not inferior in patients with high and intermediate risk patients. Sutureless aortic valves were designed to simplify the surgical aortic valve replacement. With the aid of this new technology, the invasiveness of surgery can be reduced with potential improvements in outcome.


KEY WORDS: Aortic valve stenosis - Bioprosthesis - Transcatheter aortic valve replacement

inizio pagina

Publication History

Issue published online: March 5, 2018
Article first published online: November 3, 2017
Manuscript accepted: October 31, 2017
Manuscript received: October 29, 2017

Per citare questo articolo

Isbir S. The future of surgical aortic valve replacement and the role of sutureless technology. Minerva Cardioangiol 2018;66:213-20. DOI: 10.23736/S0026-4725.17.04550-9

Corresponding author e-mail

selim.isbir@marmara.edu.tr